VOXEL SA ZY 1
Voxel S.A. provides medical services in Poland. The company offers imaging diagnostics services, including reimbursed, commercial, and private patient examinations; teleradiology services; and clinical/pharmaceutical trials. It is also involved in the sale of radiopharmaceuticals, and the leasing of land. Voxel S.A. was incorporated in 2005 and is headquartered in Kraków, Poland.
VOXEL SA ZY 1 (0NX) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, VOXEL SA ZY 1 (0NX) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
VOXEL SA ZY 1 - Net Assets Trend (None–None)
This chart illustrates how VOXEL SA ZY 1's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for VOXEL SA ZY 1 (None–None)
The table below shows the annual net assets of VOXEL SA ZY 1 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to VOXEL SA ZY 1's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
VOXEL SA ZY 1 Competitors by Market Cap
The table below lists competitors of VOXEL SA ZY 1 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Melar Acquisition Corp. I Class A Ordinary Shares
NASDAQ:MACI
|
$140.20 Million |
|
Gamania Digital Entertainment Co Ltd
TWO:6180
|
$140.21 Million |
|
Autolus Therapeutics plc
F:6A3A
|
$140.22 Million |
|
I-Sheng Electric Wire & Cable Co Ltd
TW:6115
|
$140.23 Million |
|
Ege Gubre Sanayi AS
IS:EGGUB
|
$140.15 Million |
|
Immobiliare Grande Distribuzione SIIQ S.p.A
PINK:IMMQF
|
$140.14 Million |
|
Suncha Technology Co Ltd
SHE:001211
|
$140.14 Million |
|
Blumar
SN:BLUMAR
|
$140.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in VOXEL SA ZY 1's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares VOXEL SA ZY 1's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently VOXEL SA ZY 1 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares VOXEL SA ZY 1's net assets metrics with peer companies in the Diagnostics & Research industry.
Industry Context
- Industry: Diagnostics & Research
- Average net assets among peers: $10,792,710,184
- Average return on equity (ROE) among peers: -33.38%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| VOXEL SA ZY 1 (0NX) | €- | N/A | N/A | $140.19 Million |
| Spermosens AB (publ) (9R5) | $23.64 Million | -27.17% | 0.09x | $517.28K |
| BML Inc (BMZ) | $81.13 Billion | 8.19% | 0.43x | $462.01 Million |
| Genomic Vision Société Anonyme (G09) | $3.07 Million | -162.85% | 1.21x | $711.54K |
| ICON Public Limited Company (IJF) | $1.85 Billion | 17.96% | 0.86x | $6.43 Billion |
| Adicon Holdings Limited (K0U) | $1.77 Billion | 2.65% | 1.64x | $138.53 Million |
| WuXi XDC Cayman Inc. (L74) | $1.48 Billion | 10.52% | 0.69x | $2.11 Billion |
| NanoRepro AG (NN6) | $57.61 Million | 51.59% | 0.37x | $16.84 Million |
| PERRIGO (PGO) | $24.67 Million | -167.93% | 0.99x | $6.37K |